• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Marcus O. Butler, MD

Publications

  • Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, Wang SS, Bondy M, Houlston R, Jenkins RB, Wrensch M, Yeager M, Ahlbom A, Albanes D, Andersson U, Freeman LE, Buring JE, Butler MA, Braganza M, Carreon T, Feychting M, Fleming SJ, Gapstur SM, Gaziano JM, Giles GG, Hallmans G, Henriksson R, Hoffman-Bolton J, Inskip PD, Johansen C, Kitahara CM, Lathrop M, Liu C, Le Marchand L, Linet MS, Lonn S, Peters U, Purdue MP, Rothman N, Ruder AM, Sanson M, Sesso HD, Severi G, Shu XO, Simon M, Stampfer M, Stevens VL, Visvanathan K, White E, Wolk A, Zeleniuch-Jacquotte A, Zheng W, Decker P, Enciso-Mora V, Fridley B, Gao YT, Kosel M, Lachance DH, Lau C, Rice T, Swerdlow A, Wiemels JL, Wiencke JK, Shete S, Xiang YB, Xiao Y, Hoover RN, Fraumeni JF, Chatterjee N, Hartge P, Chanock SJ.Genome-wide association study of glioma and meta-analysis.Hum Genet. 2012 Dec;131(12):1877-88.
    22886559
  • Butler MO, Ansén S, Tanaka M, Imataki O, Berezovskaya A, Mooney MM, Metzler G, Milstein MI, Nadler LM, Hirano N.A panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4+ T cells restricted by prevalent HLA-DR alleles.Int Immunol. 2010 Nov;22(11):863-73.
    21059769
  • Ansen S,Butler MO,Berezovskaya A,Murray AP,Stevenson K,Nadler LM,Hirano N.Dissociation of its opposing immunologic effects is critical for the optimization of antitumor CD8+ T-cell responses induced by interleukin 21.Clin Cancer Res. 2008 Oct 1;14(19):6125-36.
    18829491
  • Nagymanyoki Z,Butler MO,Callahan MJ,Parast MM,Fulop V,Mok SC,Berkowitz RS.Antigen-specific T cell immune response detected by skewed T cell receptor usage in normal placenta and complete molar pregnancy.J Reprod Med. 2008 Jul;53(7):528-34.
    18720929
  • Hodi FS, Butler M, Oble DA, Seiden MV, Haluska FG, Kruse A, Macrae S, Nelson M, Canning C, Lowy I, Korman A, Lautz D, Russell S, Jaklitsch MT, Ramaiya N, Chen TC, Neuberg D, Allison JP, Mihm MC, Dranoff G.Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients.Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3005-10.
    18287062
  • Butler MO, Lee JS, Ansén S, Neuberg D, Hodi FS, Murray AP, Drury L, Berezovskaya A, Mulligan RC, Nadler LM, Hirano N.Long-Lived Antitumor CD8+ Lymphocytes for Adoptive Therapy Generated Using an Artificial Antigen-Presenting Cell.Clin Cancer Res. 2007 Mar 15;13(6):1857-1867.
    17363542
  • Hirano N, Butler M, Xia Z, Berezovskaya A, Murray AP, Ansen S, Kojima S, Nadler LM.Identification of an immunogenic CD8+ T cell epitope derived from {gamma}-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemia.Blood. 2006 Oct 15;108(8):2662-8.
    16778141
  • Hirano N, Butler MO, Xia Z, Berezovskaya A, Murray AP, Ansén S, Nadler LM.Efficient presentation of naturally processed HLA class I peptides by artificial antigen-presenting cells for the generation of effective antitumor responses.Clin Cancer Res. 2006 May 15;12(10):2967-75.
    16707591
  • Maia S, Haining WN, Ansén S, Xia Z, Armstrong SA, Seth NP, Ghia P, den Boer ML, Pieters R, Sallan SE, Nadler LM, Cardoso AA.Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemia.Cancer Res. 2005 Nov 1;65(21):10050-8.
    16267031
  • Hirano N, Butler MO, Xia Z, Ansén S, von Bergwelt-Baildon MS, Neuberg D, Freeman GJ, Nadler LM.Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity.Blood. 2006 Feb 15;107(4):1528-36.
    16239433
  • Hirano N, Butler MO, Guinan EC, Nadler LM, Kojima S.Presence of anti-kinectin and anti-PMS1 antibodies in Japanese aplastic anaemia patients.Br J Haematol. 2005 Jan;128(2):221-3.
    15638857
  • Hirano N, Butler MO, Von Bergwelt-Baildon MS, Maecker B, Schultze JL, O'Connor KC, Schur PH, Kojima S, Guinan EC, Nadler LM.Autoantibodies frequently detected in patients with aplastic anemia.Blood. 2003 Dec 15;102(13):4567-75.
    12947009
  • Maecker B, Sherr DH, Vonderheide RH, von Bergwelt-Baildon MS, Hirano N, Anderson KS, Xia Z, Butler MO, Wucherpfennig KW, O'Hara C, Cole G, Kwak SS, Ramstedt U, Tomlinson AJ, Chicz RM, Nadler LM, Schultze JL.The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells.Blood. 2003 Nov 1;102(9):3287-94.
    12869499
  • Hodi FS, Mihm MC, Soiffer RJ, Haluska FG, Butler M, Seiden MV, Davis T, Henry-Spires R, MacRae S, Willman A, Padera R, Jaklitsch MT, Shankar S, Chen TC, Korman A, Allison JP, Dranoff G.Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients.Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4712-7.
    12682289
  • von Bergwelt-Baildon MS, Vonderheide RH, Maecker B, Hirano N, Anderson KS, Butler MO, Xia Z, Zeng WY, Wucherpfennig KW, Nadler LM, Schultze JL.Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application.Blood. 2002 May 1;99(9):3319-25.
    11964299
  • Vonderheide RH, Schultze JL, Anderson KS, Maecker B, Butler MO, Xia Z, Kuroda MJ, von Bergwelt-Baildon MS, Bedor MM, Hoar KM, Schnipper DR, Brooks MW, Letvin NL, Stephans KF, Wucherpfennig KW, Hahn WC, Nadler LM.Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals.Cancer Res. 2001 Dec 1;61(23):8366-70.
    11731409
  • Vonderheide RH, Anderson KS, Hahn WC, Butler MO, Schultze JL, Nadler LM.Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase.Clin Cancer Res. 2001 Nov;7(11):3343-8.
    11705846
  • Vonderheide RH, Butler MO, Liu JF, Battle TE, Hirano N, Gribben JG, Frank DA, Schultze JL, Nadler LM.CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity.Int J Oncol. 2001 Oct;19(4):791-8.
    11562757